Expression of Tumor-mediated CD137 ligand in human colon cancer indicates dual signaling effects

CD137-targeting immune therapy, which activates anti-tumor T effector cell responses, seems to be an attractive concept in clinical oncology. Recent evidence has demonstrated that tumor cells besides T cells and antigen-presenting cells are able to express CD137 and CD137L. Here we aimed to identify...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Tanja Grimmig, Martin Gasser, Romana Moench, Lang-Jing Zhu, Karol Nawalaniec, Simone Callies, Martin Wagner, Buelent Polat, Suraj Sarvode Mothi, Yueming Luo, Carmen Austrália Paredes Marcondes Ribas, Osvaldo Malafaia, Li‐Li Hsiao, Ana Maria Waaga-Gasser
Aineistotyyppi: Artigo
Kieli:englanti
Julkaistu: 2019
Linkit:https://doi.org/10.1080/2162402x.2019.1651622
https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2019.1651622?needAccess=true
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!